The Clinical Potential of Interleukin-2
Author Information
Author(s): R.T.D. Oliver
Primary Institution: The London Hospital Medical College
Hypothesis
Can interleukin-2 (IL-2) be an effective treatment for cancer?
Conclusion
Interleukin-2 shows promise as a treatment for certain types of cancer, particularly in combination with other therapies.
Supporting Evidence
- IL-2 has induced complete remission in advanced metastatic diseases.
- The combination of IL-2 and LAK cells has shown synergistic effects in eliminating tumors.
- Preliminary results suggest IL-2 may be effective in chemosensitive tumors as well.
Takeaway
Interleukin-2 is a substance that helps the immune system fight cancer, and it has shown good results in some patients.
Methodology
The review discusses the role of IL-2 in immune response and evaluates results from initial phase I/II clinical trials.
Potential Biases
There is a risk of over-enthusiastic publicity affecting the perception of IL-2's effectiveness.
Limitations
The treatment has high toxicity and requires careful management.
Participant Demographics
Patients with advanced cancer, primarily those with chemotherapy-resistant tumors.
Want to read the original?
Access the complete publication on the publisher's website